Proinflammatory cytokinemia associated with transient myeloproliferative disorder in down syndrome

Akira Shimada, Kenichi Maruyama, Toshiji Shitara, Masahiko Kato, Kazutoshi Cho, Tohru Kobayashi, Toru Fujiu, Yoshiaki Tsuchida, Akira Nishida, Yasuhide Hayashi, Hisanori Minakami, Kunihisa Kozawa, Hirokazu Kimura

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A transient myeloproliferative disorder (TMD) occurs in 10% of the infants with Down syndrome. While most cases resolve within a few months, in 20% of them TMDs are life-threatening or fatal. We encountered 4 patients with TMD, including 1 patient who died of liver failure and disseminated intravascular coagulation. Suspecting involvement of proinflammatory cytokines, we serially assayed them in patients' sera. Cytokines were significantly more abundant in patients than in controls. Interleukins 1 and 2, tumor necrosis factor alpha, interferon gamma, and granulocyte-macrophage colony-stimulating factor were greatly increased, especially in the infant who died. Sustained cytokinemia is likely to participate in TMD pathophysiology, and very high serum concentrations might predict a poor outcome.

Original languageEnglish
Pages (from-to)167-172
Number of pages6
JournalBiology of the Neonate
Volume85
Issue number3
DOIs
Publication statusPublished - 2004
Externally publishedYes

Fingerprint

Myeloproliferative Disorders
Cytokines
Disseminated Intravascular Coagulation
Liver Failure
Granulocyte-Macrophage Colony-Stimulating Factor
Down Syndrome
Serum
Interleukin-1
Interferon-alpha
Interferon-gamma
Interleukin-2
Tumor Necrosis Factor-alpha
Transient Myeloproliferative Disorder of Down Syndrome

Keywords

  • Down syndrome
  • Proinflammatory cytokines
  • Transient myeloproliferative disorder

ASJC Scopus subject areas

  • Developmental Biology
  • Pediatrics, Perinatology, and Child Health

Cite this

Proinflammatory cytokinemia associated with transient myeloproliferative disorder in down syndrome. / Shimada, Akira; Maruyama, Kenichi; Shitara, Toshiji; Kato, Masahiko; Cho, Kazutoshi; Kobayashi, Tohru; Fujiu, Toru; Tsuchida, Yoshiaki; Nishida, Akira; Hayashi, Yasuhide; Minakami, Hisanori; Kozawa, Kunihisa; Kimura, Hirokazu.

In: Biology of the Neonate, Vol. 85, No. 3, 2004, p. 167-172.

Research output: Contribution to journalArticle

Shimada, A, Maruyama, K, Shitara, T, Kato, M, Cho, K, Kobayashi, T, Fujiu, T, Tsuchida, Y, Nishida, A, Hayashi, Y, Minakami, H, Kozawa, K & Kimura, H 2004, 'Proinflammatory cytokinemia associated with transient myeloproliferative disorder in down syndrome', Biology of the Neonate, vol. 85, no. 3, pp. 167-172. https://doi.org/10.1159/000075376
Shimada, Akira ; Maruyama, Kenichi ; Shitara, Toshiji ; Kato, Masahiko ; Cho, Kazutoshi ; Kobayashi, Tohru ; Fujiu, Toru ; Tsuchida, Yoshiaki ; Nishida, Akira ; Hayashi, Yasuhide ; Minakami, Hisanori ; Kozawa, Kunihisa ; Kimura, Hirokazu. / Proinflammatory cytokinemia associated with transient myeloproliferative disorder in down syndrome. In: Biology of the Neonate. 2004 ; Vol. 85, No. 3. pp. 167-172.
@article{232ba58fe50048ec884688bbf06d7378,
title = "Proinflammatory cytokinemia associated with transient myeloproliferative disorder in down syndrome",
abstract = "A transient myeloproliferative disorder (TMD) occurs in 10{\%} of the infants with Down syndrome. While most cases resolve within a few months, in 20{\%} of them TMDs are life-threatening or fatal. We encountered 4 patients with TMD, including 1 patient who died of liver failure and disseminated intravascular coagulation. Suspecting involvement of proinflammatory cytokines, we serially assayed them in patients' sera. Cytokines were significantly more abundant in patients than in controls. Interleukins 1 and 2, tumor necrosis factor alpha, interferon gamma, and granulocyte-macrophage colony-stimulating factor were greatly increased, especially in the infant who died. Sustained cytokinemia is likely to participate in TMD pathophysiology, and very high serum concentrations might predict a poor outcome.",
keywords = "Down syndrome, Proinflammatory cytokines, Transient myeloproliferative disorder",
author = "Akira Shimada and Kenichi Maruyama and Toshiji Shitara and Masahiko Kato and Kazutoshi Cho and Tohru Kobayashi and Toru Fujiu and Yoshiaki Tsuchida and Akira Nishida and Yasuhide Hayashi and Hisanori Minakami and Kunihisa Kozawa and Hirokazu Kimura",
year = "2004",
doi = "10.1159/000075376",
language = "English",
volume = "85",
pages = "167--172",
journal = "Neonatology",
issn = "1661-7800",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Proinflammatory cytokinemia associated with transient myeloproliferative disorder in down syndrome

AU - Shimada, Akira

AU - Maruyama, Kenichi

AU - Shitara, Toshiji

AU - Kato, Masahiko

AU - Cho, Kazutoshi

AU - Kobayashi, Tohru

AU - Fujiu, Toru

AU - Tsuchida, Yoshiaki

AU - Nishida, Akira

AU - Hayashi, Yasuhide

AU - Minakami, Hisanori

AU - Kozawa, Kunihisa

AU - Kimura, Hirokazu

PY - 2004

Y1 - 2004

N2 - A transient myeloproliferative disorder (TMD) occurs in 10% of the infants with Down syndrome. While most cases resolve within a few months, in 20% of them TMDs are life-threatening or fatal. We encountered 4 patients with TMD, including 1 patient who died of liver failure and disseminated intravascular coagulation. Suspecting involvement of proinflammatory cytokines, we serially assayed them in patients' sera. Cytokines were significantly more abundant in patients than in controls. Interleukins 1 and 2, tumor necrosis factor alpha, interferon gamma, and granulocyte-macrophage colony-stimulating factor were greatly increased, especially in the infant who died. Sustained cytokinemia is likely to participate in TMD pathophysiology, and very high serum concentrations might predict a poor outcome.

AB - A transient myeloproliferative disorder (TMD) occurs in 10% of the infants with Down syndrome. While most cases resolve within a few months, in 20% of them TMDs are life-threatening or fatal. We encountered 4 patients with TMD, including 1 patient who died of liver failure and disseminated intravascular coagulation. Suspecting involvement of proinflammatory cytokines, we serially assayed them in patients' sera. Cytokines were significantly more abundant in patients than in controls. Interleukins 1 and 2, tumor necrosis factor alpha, interferon gamma, and granulocyte-macrophage colony-stimulating factor were greatly increased, especially in the infant who died. Sustained cytokinemia is likely to participate in TMD pathophysiology, and very high serum concentrations might predict a poor outcome.

KW - Down syndrome

KW - Proinflammatory cytokines

KW - Transient myeloproliferative disorder

UR - http://www.scopus.com/inward/record.url?scp=12144290017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12144290017&partnerID=8YFLogxK

U2 - 10.1159/000075376

DO - 10.1159/000075376

M3 - Article

VL - 85

SP - 167

EP - 172

JO - Neonatology

JF - Neonatology

SN - 1661-7800

IS - 3

ER -